DETAILED ACTION
1. Claims 1-20 are pending in the instant application.
Applicant's election without traverse of group (III), claims 1-13, wherein X is C, R3 is five membered heterocyclic ring, which the heteroatom is only N in the reply filed on 08/05/2026 is acknowledged.
The requirement is still deemed proper and is therefore made FINAL.
Claims 1-13 in part wherein X is C, R3 is five membered heterocyclic ring, which the heteroatom is only N are examined. Claims 14-20 and the remaining subject matter of claims 1-13 are withdrawn per 37 CFR 1.142(b).
2. Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 1-13 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Rhodes et al., WO 2022261068. Rhodes et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image1.png
382
760
media_image1.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Rhodes et al.
3. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Kim et al., US 20170057955. Kim et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image2.png
542
756
media_image2.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Kim et al.
4. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Saitoh et al., US 10201531. Saitoh et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image3.png
238
712
media_image3.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Saitoh et al.
5. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Bereznak et al., US 9730447. Bereznak et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image4.png
70
748
media_image4.png
Greyscale
PNG
media_image5.png
568
760
media_image5.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Bereznak et al.
6. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Basso et al., US 20100249030. Basso et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image6.png
282
770
media_image6.png
Greyscale
,
PNG
media_image7.png
82
752
media_image7.png
Greyscale
PNG
media_image8.png
340
566
media_image8.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Basso et al.
7. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Shipps et al., US 8318735. Shipps et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image9.png
72
782
media_image9.png
Greyscale
PNG
media_image10.png
750
770
media_image10.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Shipps et al.
8. Claims 1-13 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Cosford et al., US 7569592. Cosford et al. discloses the instant claimed compound, which from the STN search is
PNG
media_image11.png
200
690
media_image11.png
Greyscale
, which anticipates the instant compounds. Therefore, the instant claims are anticipated by Cosford et al.
9. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Niloofar Rahmani whose telephone number is
571-272-4329. The examiner can normally be reached on Monday through Friday from 8:30 am to 5:00 pm.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Renee Claytor, can be reached on 571-272-8394. The fax phone number for the organization where this application or proceeding is assigned is 703-872-9306.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free).
/NILOOFAR RAHMANI/ Primary Examiner, Art Unit 1691 08/19/2026
Prosecution Insights